Page 86 - Read Online
P. 86

Page 10 of 13                  Zeng et al. Cancer Drug Resist 2024;7:31  https://dx.doi.org/10.20517/cdr.2024.57

               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2024.


               REFERENCES
               1.       Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis
                    Primers 2020;6:92.  DOI  PubMed  PMC
               2.       Sacco AG, Cohen EE. Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma. J Clin Oncol
                    2015;33:3305-13.  DOI  PubMed
               3.       Beermann J, Piccoli MT, Viereck J, Thum T. Non-coding RNAs in development and disease: background, mechanisms, and
                    therapeutic approaches. Physiol Rev 2016;96:1297-325.  DOI  PubMed
               4.       Suzuki H, Zuo Y, Wang J, Zhang MQ, Malhotra A, Mayeda A. Characterization of RNase R-digested cellular RNA source that
                    consists of lariat and circular RNAs from pre-mRNA splicing. Nucleic Acids Res 2006;34:e63.  DOI  PubMed  PMC
               5.       Harper KL, Mcdonnell E, Whitehouse A. CircRNAs: from anonymity to novel regulators of gene expression in cancer (Review). Int J
                    Oncol 2019;55:1183-93.  DOI  PubMed
               6.       Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol 2020;21:475-90.
                    DOI  PubMed
               7.       Wu P, Mo Y, Peng M, et al. Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol Cancer
                    2020;19:22.  DOI  PubMed  PMC
               8.       Yang Y, Wang Y, Wang F, et al. The roles of miRNA, lncRNA and circRNA in the development of osteoporosis. Biol Res
                    2020;53:40.  DOI  PubMed  PMC
               9.       Yong-Deok K, Eun-Hyoung J, Yeon-Sun K, et al. Molecular genetic study of novel biomarkers for early diagnosis of oral squamous
                    cell carcinoma. Med Oral Patol Oral Cir Bucal 2015;20:e167-79.  DOI  PubMed  PMC
               10.       Zhang SJ, Chen X, Li CP, et al. Identification and characterization of circular RNAs as a new class of putative biomarkers in diabetes
                    retinopathy. Invest Ophthalmol Vis Sci 2017;58:6500-9.  DOI  PubMed
               11.       Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res
                    2015;25:981-4.  DOI  PubMed  PMC
               12.       Dang QQ, Li PH, Wang J, et al. CircMAN1A2 contributes to nasopharyngeal carcinoma progression via enhancing the ubiquitination
                    of ATMIN through miR-135a-3p/UBR5 axis. Hum Cell 2023;36:657-75.  DOI  PubMed
               13.       Luo Y, Ma J, Liu F, Guo J, Gui R. Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma. Head Neck
                    2020;42:3702-11.  DOI  PubMed
               14.       Liu R, Zhou M, Zhang P, Zhao Y, Zhang Y. Cell proliferation and invasion is promoted by circSERPINA3 in nasopharyngeal
                    carcinoma by regulating miR-944/MDM2 axis. J Cancer 2020;11:3910-8.  DOI  PubMed  PMC
               15.       He W, Zhou X, Mao Y, et al. CircCRIM1 promotes nasopharyngeal carcinoma progression via the miR-34c-5p/FOSL1 axis. Eur J
                    Med Res 2022;27:59.  DOI  PubMed  PMC
               16.       Shuai M, Huang L. High expression of hsa_circRNA_001387 in nasopharyngeal carcinoma and the effect on efficacy of
                    radiotherapy. Onco Targets Ther 2020;13:3965-73.  DOI  PubMed  PMC
               17.       Sufianov A, Begliarzade S, Kudriashov V, et al. The role of circular RNAs in the pathophysiology of oral squamous cell carcinoma.
                    Noncoding RNA Res 2023;8:109-14.  DOI  PubMed  PMC
               18.       Li  L,  Zhang  ZT.  Hsa_circ_0086414  might  be  a  diagnostic  biomarker  of  oral  squamous  cell  carcinoma.  Med  Sci  Monit
                    2020;26:e919383.  DOI  PubMed  PMC
               19.       Zhao SY, Wang J, Ouyang SB, Huang ZK, Liao L. Salivary circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as novel
                    biomarkers for the diagnosis of oral squamous cell carcinoma. Cell Physiol Biochem 2018;47:2511-21.  DOI  PubMed
               20.       Kan X, Sun Y, Lu J, et al. Co-inhibition of miRNA-21 and miRNA-221 induces apoptosis by enhancing the p53-mediated
                    expression of pro-apoptotic miRNAs in laryngeal squamous cell carcinoma. Mol Med Rep 2016;13:4315-20.  DOI  PubMed
               21.       Yin L, Chen J, Ma C, et al. Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by
                    upregulating IGFBP3. Cell Death Dis 2020;11:562.  DOI  PubMed  PMC
               22.       Li M, Li Y, Yu M. CircRNA ZNF609 knockdown suppresses cell growth via modulating miR-188/ELF2 axis in nasopharyngeal
                    carcinoma. Onco Targets Ther 2020;13:2399-409.  DOI  PubMed  PMC
               23.       Wang J, Lin Y, Jiang DH, Yang X, He XG. CircRNA ZNF609 promotes angiogenesis in nasopharyngeal carcinoma by regulating
                    miR-145/STMN1 axis. Kaohsiung J Med Sci 2021;37:686-98.  DOI  PubMed
               24.       Zhu L, Liu Y, Yang Y, Mao XM, Yin ZD. CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by
                    competing with microRNA-150-5p. Eur Rev Med Pharmacol Sci 2019;23:2817-26.  DOI  PubMed
               25.       Zhao Y, Li C, Zhang Y, Li Z. CircTMTC1 contributes to nasopharyngeal carcinoma progression through targeting miR-495-MET-
                    eIF4G1 translational regulation axis. Cell Death Dis 2022;13:250.  DOI  PubMed  PMC
   81   82   83   84   85   86   87   88   89   90   91